Evosep introduces a novel separation solution designed for clinical omics at HUPO 2017
Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. We will make sample preparation and separation for mass spectrometry analysis 100 times more robust and 10 times faster to enable truly large cohort studies and provide the foundation for precision medicine.
What matters in clinical proteomics? 2. The need for standardization
Many areas in clinical proteomics could benefit from a broader adoption of liquid chromatography mass spectrometry (LC/MS) methods. What needs to be done to make LC/MS a standard technique in the clinic?
What matters in clinical proteomics? 1. Challenges of large cohort studies
Cohort studies are essential in the discovery and validation of protein biomarkers. Every day, clinical proteomics labs evaluate patient samples to correlate protein patterns with a specific status – e.g., healthy vs. pathogenic, or therapeutically responsive vs. non-responsive.
